Advertisement
UK markets close in 3 hours 15 minutes
  • FTSE 100

    8,036.76
    +12.89 (+0.16%)
     
  • FTSE 250

    19,693.55
    +94.16 (+0.48%)
     
  • AIM

    753.52
    +4.34 (+0.58%)
     
  • GBP/EUR

    1.1620
    +0.0031 (+0.27%)
     
  • GBP/USD

    1.2402
    +0.0051 (+0.42%)
     
  • Bitcoin GBP

    53,260.51
    +164.73 (+0.31%)
     
  • CMC Crypto 200

    1,420.23
    +5.47 (+0.39%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CRUDE OIL

    81.25
    -0.65 (-0.79%)
     
  • GOLD FUTURES

    2,319.30
    -27.10 (-1.15%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,034.38
    +173.58 (+0.97%)
     
  • CAC 40

    8,076.66
    +36.30 (+0.45%)
     

Should You Buy Boston Scientific Corporation (NYSE:BSX) Now?

Let’s talk about the popular Boston Scientific Corporation (NYSE:BSX). The company’s shares saw a significant share price rise of over 20% in the past couple of months on the NYSE. With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. But what if there is still an opportunity to buy? Let’s take a look at Boston Scientific’s outlook and value based on the most recent financial data to see if the opportunity still exists. View out our latest analysis for Boston Scientific

What’s the opportunity in Boston Scientific?

Boston Scientific appears to be overvalued by 29.5% at the moment, based on my discounted cash flow valuation. The stock is currently priced at US$31.92 on the market compared to my intrinsic value of $24.65. Not the best news for investors looking to buy! In addition to this, it seems like Boston Scientific’s share price is quite stable, which could mean two things: firstly, it may take the share price a while to fall back down to an attractive buying range, and secondly, there may be less chances to buy low in the future once it reaches that value. This is because the stock is less volatile than the wider market given its low beta.

What does the future of Boston Scientific look like?

NYSE:BSX Future Profit June 22nd 18
NYSE:BSX Future Profit June 22nd 18

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company’s future expectations. With profit expected to more than double over the next couple of years, the future seems bright for Boston Scientific. It looks like higher cash flows is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? It seems like the market has well and truly priced in BSX’s positive outlook, with shares trading above its fair value. However, this brings up another question – is now the right time to sell? If you believe BSX should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping tabs on BSX for some time, now may not be the best time to enter into the stock. The price has surpassed its true value, which means there’s no upside from mispricing. However, the optimistic prospect is encouraging for BSX, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Boston Scientific. You can find everything you need to know about Boston Scientific in the latest infographic research report. If you are no longer interested in Boston Scientific, you can use our free platform to see my list of over 50 other stocks with a high growth potential.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.